2834 – Page 185 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Beginssembly of New Production Linereases overallpacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostarmpleted Chinese Military Drugministration clinical trials for Zushima Analgesicrosolray (Zushima) in April through the Chinese No. 4 Military Medical University. Zushima is a traditional Chinese]

By info| 2016-02-07T17:23:04+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-05-25, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Beginssembly of New Production Linereases overallpacity

[Biostar Pharmaceuticals, Beginssembly of New Production Linereases overallpacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostarmpleted Chinese Military Drugministration clinical trials for Zushima Analgesicrosolray (Zushima) in April through the Chinese No. 4 Military Medical University. Zushima is a traditional Chinese]

By info| 2016-02-07T17:23:59+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2010-05-25, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited First Quarter 2010 Financial Results - Conference call scheduled for Thursday, May 13, 2010 at 8:00 PM EDT Sinovac Biotech Ltd. ( Beijing May 13, 2010 NASDAQ: SVA), a leading China-based vaccine manufacturer , announc ed today its un audited financial results for the three-month period ended March 31, 2010. First Quarter 2010 Financial] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By info| 2016-03-24T03:06:19+00:00 May 19th, 2010|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2010-05-19, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Quarter 2010 Financial Results

[Sinovac Reports Unaudited First Quarter 2010 Financial Results - Conference call scheduled for Thursday, May 13, 2010 at 8:00 PM EDT Sinovac Biotech Ltd. ( Beijing May 13, 2010 NASDAQ: SVA), a leading China-based vaccine manufacturer , announc ed today its un audited financial results for the three-month period ended March 31, 2010. First Quarter 2010 Financial] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By info| 2016-03-24T03:08:05+00:00 May 19th, 2010|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2010-05-19, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]

By info| 2016-03-01T06:07:27+00:00 May 18th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2010-05-18, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]

By info| 2016-03-01T06:08:15+00:00 May 18th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2010-05-18, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[NEWS RELEASEystar Bio-Pharmaceutical Reports 27% Growth in Revenue Fromntinuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidancereased to $45.5 Million to $47.5 Million XIAN, CHINA May 18, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"),]

By info| 2016-02-05T04:16:31+00:00 May 18th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2010-05-18, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Reports 27% Growth in Revenue

[NEWS RELEASEystar Bio-Pharmaceutical Reports 27% Growth in Revenue Fromntinuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidancereased to $45.5 Million to $47.5 Million XIAN, CHINA May 18, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"),]